Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers

Previous studies have shown activation of the immune system and altered immune response in Huntington's disease (HD) gene carriers. Here, we hypothesized that peripheral and central immune responses could be concurrent pathophysiological events and represent a global innate immune response to t...

Full description

Bibliographic Details
Main Authors: Marios Politis, Nayana Lahiri, Flavia Niccolini, Paul Su, Kit Wu, Paolo Giannetti, Rachael I. Scahill, Federico E. Turkheimer, Sarah J. Tabrizi, Paola Piccini
Format: Article
Language:English
Published: Elsevier 2015-11-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996115300322
_version_ 1818337312135708672
author Marios Politis
Nayana Lahiri
Flavia Niccolini
Paul Su
Kit Wu
Paolo Giannetti
Rachael I. Scahill
Federico E. Turkheimer
Sarah J. Tabrizi
Paola Piccini
author_facet Marios Politis
Nayana Lahiri
Flavia Niccolini
Paul Su
Kit Wu
Paolo Giannetti
Rachael I. Scahill
Federico E. Turkheimer
Sarah J. Tabrizi
Paola Piccini
author_sort Marios Politis
collection DOAJ
description Previous studies have shown activation of the immune system and altered immune response in Huntington's disease (HD) gene carriers. Here, we hypothesized that peripheral and central immune responses could be concurrent pathophysiological events and represent a global innate immune response to the toxic effects of mutant huntingtin in HD gene carriers. We sought to investigate our hypothesis using [11C]PK11195 PET as a translocator protein (TSPO) marker of central microglial activation, together with assessment of peripheral plasma cytokine levels in a cohort of premanifest HD gene carriers who were more than a decade from predicted symptomatic conversion. Data were also compared to those from a group of healthy controls matched for age and gender. We found significantly increased peripheral plasma IL-1β levels in premanifest HD gene carriers compared to the group of normal controls (P = 0.018). Premanifest HD gene carriers had increased TSPO levels in cortical, basal ganglia and thalamic brain regions (P < 0.001). Increased microglial activation in somatosensory cortex correlated with higher plasma levels of IL-1β (rs = 0.87, P = 0.013), IL-6 (rs = 0.85, P = 0.013), IL-8 (rs = 0.68, P = 0.045) and TNF-α (rs = 0.79; P = 0.013). Our findings provide first in vivo evidence for an association between peripheral and central immune responses in premanifest HD gene carriers, and provide further supporting evidence for the role of immune dysfunction in the pathogenesis of HD.
first_indexed 2024-12-13T14:53:13Z
format Article
id doaj.art-db7b12c187ca4b4c806a502eb4484aa6
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-13T14:53:13Z
publishDate 2015-11-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-db7b12c187ca4b4c806a502eb4484aa62022-12-21T23:41:18ZengElsevierNeurobiology of Disease1095-953X2015-11-0183115121Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriersMarios Politis0Nayana Lahiri1Flavia Niccolini2Paul Su3Kit Wu4Paolo Giannetti5Rachael I. Scahill6Federico E. Turkheimer7Sarah J. Tabrizi8Paola Piccini9Neurodegeneration Imaging Group, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Division of Brain Sciences, Department of Medicine, Imperial College London, London, UKHuntington's Disease Research Group, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UKNeurodegeneration Imaging Group, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Division of Brain Sciences, Department of Medicine, Imperial College London, London, UKDivision of Brain Sciences, Department of Medicine, Imperial College London, London, UKDivision of Brain Sciences, Department of Medicine, Imperial College London, London, UKDivision of Brain Sciences, Department of Medicine, Imperial College London, London, UKHuntington's Disease Research Group, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UKDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UKHuntington's Disease Research Group, Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, UKDivision of Brain Sciences, Department of Medicine, Imperial College London, London, UK; Corresponding author at: Division of Brian Sciences, Imperial College London, Hammersmith Hospital Campus, DuCane road, W12 0NN London, UK.Previous studies have shown activation of the immune system and altered immune response in Huntington's disease (HD) gene carriers. Here, we hypothesized that peripheral and central immune responses could be concurrent pathophysiological events and represent a global innate immune response to the toxic effects of mutant huntingtin in HD gene carriers. We sought to investigate our hypothesis using [11C]PK11195 PET as a translocator protein (TSPO) marker of central microglial activation, together with assessment of peripheral plasma cytokine levels in a cohort of premanifest HD gene carriers who were more than a decade from predicted symptomatic conversion. Data were also compared to those from a group of healthy controls matched for age and gender. We found significantly increased peripheral plasma IL-1β levels in premanifest HD gene carriers compared to the group of normal controls (P = 0.018). Premanifest HD gene carriers had increased TSPO levels in cortical, basal ganglia and thalamic brain regions (P < 0.001). Increased microglial activation in somatosensory cortex correlated with higher plasma levels of IL-1β (rs = 0.87, P = 0.013), IL-6 (rs = 0.85, P = 0.013), IL-8 (rs = 0.68, P = 0.045) and TNF-α (rs = 0.79; P = 0.013). Our findings provide first in vivo evidence for an association between peripheral and central immune responses in premanifest HD gene carriers, and provide further supporting evidence for the role of immune dysfunction in the pathogenesis of HD.http://www.sciencedirect.com/science/article/pii/S0969996115300322Huntington's diseaseMicrogliaPeripheral inflammationPETMRI
spellingShingle Marios Politis
Nayana Lahiri
Flavia Niccolini
Paul Su
Kit Wu
Paolo Giannetti
Rachael I. Scahill
Federico E. Turkheimer
Sarah J. Tabrizi
Paola Piccini
Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
Neurobiology of Disease
Huntington's disease
Microglia
Peripheral inflammation
PET
MRI
title Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
title_full Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
title_fullStr Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
title_full_unstemmed Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
title_short Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers
title_sort increased central microglial activation associated with peripheral cytokine levels in premanifest huntington s disease gene carriers
topic Huntington's disease
Microglia
Peripheral inflammation
PET
MRI
url http://www.sciencedirect.com/science/article/pii/S0969996115300322
work_keys_str_mv AT mariospolitis increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT nayanalahiri increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT flavianiccolini increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT paulsu increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT kitwu increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT paologiannetti increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT rachaeliscahill increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT federicoeturkheimer increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT sarahjtabrizi increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers
AT paolapiccini increasedcentralmicroglialactivationassociatedwithperipheralcytokinelevelsinpremanifesthuntingtonsdiseasegenecarriers